Caris Life Sciences Inc.
CAI | NASDAQ
$32.87
-$1.46 (-4.25%)
Nov 2, 2026, 12:18 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | 48.16 | -11.46 | -13.84 | -12.30 | -9.28 | -21.54 | -19.58 | -23.14 | -31.82 | -52.83 | 3.55 | 4.81 | 7.55 |
PEG Ratio | 1.73 | 0.11 | -0.06 | 0.12 | -0.02 | -0.26 | 0.59 | 4.05 | 0.94 | n/a | 0.08 | n/a | 0.05 |
PS Ratio | 5.09 | 5.57 | 9.38 | 13.15 | 13.44 | 15.77 | 19.09 | 27.88 | 39.47 | 88.43 | 1.46 | 1.56 | 1.61 |
PB Ratio | 8.52 | 8.51 | 13.19 | 17.84 | 15.84 | -2.74 | -28.39 | n/a | n/a | -362.76 | 0.61 | 0.64 | 0.67 |
P/FCF Ratio | 34.41 | 40.92 | 113.87 | -609.27 | -51.02 | -33.65 | -31.03 | -37.05 | -50.53 | -94.29 | -0.74 | -3.23 | -6.85 |
P/OCF Ratio | 25.03 | 34.28 | 91.60 | -15.63K | -54.18 | -35.21 | -32.10 | -38.16 | -52.13 | -96.50 | 1.43 | 1.54 | 1.65 |
OCF/S Ratio | 23.27 | 15.21 | 15.29 | 28.79 | 4.02 | -25.92 | -29.96 | -68.32 | -62.90 | -91.63 | 96.81 | 100.68 | 93.80 |
Debt / Equity Ratio | 0.76 | 0.73 | 0.66 | 0.89 | 0.93 | -0.16 | -1.53 | n/a | n/a | n/a | 2.82 | 2.41 | 2.52 |
Quick Ratio | 4.88 | 7.05 | 7.85 | 9.36 | 8.79 | 0.83 | 1.06 | n/a | n/a | n/a | 0.72 | 0.45 | 0.74 |
Current Ratio | 5.53 | 7.05 | 7.85 | 9.93 | 9.24 | 1.05 | 1.30 | n/a | n/a | n/a | 0.72 | 0.45 | 0.74 |
Asset Turnover | 0.21 | 0.19 | 0.26 | 0.22 | 0.19 | 0.41 | 0.38 | n/a | n/a | n/a | 0.03 | 0.03 | 0.03 |
Interest Coverage | 2.92 | 0.41 | 7.79 | 2.42 | 0.94 | -4.53 | -2.79 | -4.41 | 4.90 | -9.93 | n/a | 4.57 | 4.36 |
Return on Equity | -0.11% | -0.09% | 14.20% | 5.08% | -15.85% | 3.95% | 13.33% | n/a | n/a | 564.57% | 6.39% | 5.02% | 4.92% |
Return on Assets | -0.05% | -0.04% | 7.28% | 2.47% | -7.52% | -35.18% | -10.75% | n/a | n/a | n/a | 1.57% | 1.28% | 1.34% |
Return on Invested Capital | 2.58% | 0.41% | 8.85% | 3.61% | 2.06% | -29.70% | -15.15% | n/a | n/a | n/a | 2.01% | 1.86% | 1.76% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.53% | 1.53% | 1.53% |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.49% | 19.52% | 20.70% |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.65% | -38.18% | -7.68% |
Gross Profit Margin | 68.10% | 65.39% | 75.43% | 68.03% | 62.67% | 47.19% | 54.42% | 43.70% | 37.54% | 32.37% | 53.64% | 100% | 47.76% |
Net Profit Margin | -0.24% | -0.24% | 27.98% | 11.22% | -39.58% | -84.84% | -28.44% | -66.65% | -66.15% | -137.62% | 50.74% | 44.28% | 44.23% |
Pretax Profit Margin | -0.23% | -0.30% | 27.98% | 11.22% | -39.58% | -84.84% | -28.44% | -66.65% | -66.15% | -137.62% | 54.38% | 46.44% | 46.02% |
Operating Profit Margin | 10.21% | 2.44% | 30.19% | 15.05% | 9.92% | -47.93% | -28.52% | -59.87% | 66.98% | -114.31% | 65.90% | 59.33% | 60.35% |
FCF Margin | 10.97% | 10.42% | 13.55% | 25.52% | 3.25% | -28.14% | -31.72% | -70.12% | -65.48% | -93.79% | -443.89% | -21.94% | -118.64% |
EBITDA Margin | 5.75% | 7.97% | 33.32% | 19.69% | -25.45% | -68.44% | -21.54% | -49.51% | -40.88% | -104.16% | 87% | 59.41% | 95.44% |
Add to Watchlist
Select watchlists to add or remove CAI